Mr. Gan · haixiao@sungolytest.com · +86 158 2169 5110 · +86 132 4819 8029Mr. Luo · jun.luo@sungoglobal.com · +86 177 5560 4650

QEO

Light Attenuation Lenses For Migraine-Associated Light Sensitivity

Product code
QEO
Device name
Light Attenuation Lenses For Migraine-Associated Light Sensitivity
Device class
Class 1
21 CFR
21 CFR 882.5811
Medical specialty
Neurology
Marketing pathway
510(K) Exempt
510(k) clearances (last 3 years)
1
Summaries archived here
0 (direct download)
510(k) clearances (all years, FDA)
1 (all years; only the last 3 years are listed here)

FDA classification definition

Light attenuation lenses for migraine-associated light sensitivity are devices that limit light incidence of specific wavelengths to the eyes and are intended to decrease the impact of light sensitivity in patients diagnosed with migraine. The lenses can be mounted on a spectacle frame, clips, or other apertures used to hold lenses. The device is intended to be adjunctive to other therapies for migraine-associated light sensitivity. Sunglasses (nonprescription) and prescription spectacle lenses are separately classified under § 886.5850 and § 886.5844, respectively.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-08-21.

NumberDecision dateApplicantDevice nameSummary
DEN2500262026-08-21Matap Ii, LLCAvulux—
Official FDA classification page: QEO
Classification and pathway per current FDA publications. Data from openFDA (CC0).